Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis
CONCLUSION: Our findings suggest that copeptin may be a promising biomarker of microcirculation alterations in systemic sclerosis.PMID:37255624 | PMC:PMC10226486 | DOI:10.2147/CCID.S409490
Source: Clinical, Cosmetic and Investigational Dermatology - Category: Dermatology Authors: Magdalena Maciejewska Albert Stec Micha ł Zaremba Cezary Maciejewski Lidia Rudnicka Mariusz Sikora Source Type: research
More News: Cardiology | Dermatology | Heart | Information Technology | Raynaud's Phenomenom | Scleroderma | Skin | Study | Women